Showing 1 - 16 results of 16 for search 'Aimin Li', query time: 0.02s
Refine Results
-
1
Advanced technologies and innovative practices to promote zero-waste strategy by Aimin Li, Lili Liu
Published 2025-06-01Get full text
Article -
2
Recovery of the Dye Intermediate DNDS from Aqueous Solution by Adsorption onto Resins by Wei-Ben Yang, Jun Fan, Aimin Li, Quanxing Zhang
Published 2006-12-01Get full text
Article -
3
Application of Distribute File System & MPP Database Mashup Architecture in Telecom Big Data Platform by Yu Zhang, Xin Cai, Aimin Li, Yi Liu, Xiaohui Yao
Published 2013-11-01Get full text
Article -
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
Machine learning based predictive model of the risk of Tourette syndrome with SHAP value interpretation: a retrospective observational study by Aimin Li, Yueying Liu, Yufan Luo, Xue Xiao, Wei Xiao, Ruijin Xie, Xianhui Deng, Zhe Chen, Qian Zhou, Yue Gong, Zhen Chen, Hua Xu
Published 2025-05-01Get full text
Article -
13
Aurora kinase A promotes hepatic stellate cell activation and liver fibrosis through the Wnt/β-catenin pathway by Guanqi Dai, Guanqi Dai, Junhao Lin, Yuchuan Jiang, Yuchuan Jiang, Xinhui Liu, Peng Chen, Yixiao Zhang, Zhenghui Song, Xuefen Zhuang, Jinge Cong, Yingchun Li, Xuanjia Hong, Yun Liu, Dong Xiao, Dong Xiao, Aimin Li, Yue Luo
Published 2025-01-01Get full text
Article -
14
Effectiveness and safety of ceftazidime-avibactam in Chinese patients with hospital-acquired pneumonia, including ventilator-associated pneumonia: A Phase 4, multi-centre, open-lab... by Jinyi Yuan, Haihui Huang, Fei Guo, Aimin Li, NanYan Xu, Xiaoyue Chang, Zuke Xiao, Huiqing Zeng, Hua Qiao, Liangfa Tang, Yunsong Yu, Bin Liu, Panpan Wang, Paurus Irani, Rienk Pypstra, Junchao Lu, Fanglei Liu, Yuting Mu, Yingyuan Zhang
Published 2025-06-01Get full text
Article -
15
CEACAM1 as a mediator of B-cell receptor signaling in mantle cell lymphoma by Serene Xavier, Vivian Nguyen, Vishal Khairnar, An Phan, Lu Yang, Michael S. Nelson, Ravi P. Shukla, Jinhui Wang, Aimin Li, Huimin Geng, Jaewoong Lee, Teresa Sadras, Lan V. Pham, Dennis D. Weisenburger, Wing C. Chan, Karl S. Lang, Geoffrey P. Shouse, Alexey V. Danilov, Joo Y. Song, Samir Parekh, Markus Müschen, Vu N. Ngo
Published 2025-05-01Get full text
Article -
16
Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial by Chuanhua Zhao, Yanqiao Zhang, Gang Wang, Jinfang Zheng, Weiqing Chen, Zheng Lu, Li Zhuang, Shanzhi Gu, Lei Han, Zhendong Zheng, Zujiang Yu, Yongsheng Yang, Hongmei Sun, Xiaoyong Wei, Ying Cheng, Hailan Lin, Bo Zhu, Guicheng Wu, Kaijian Lei, Wei Wang, Yuwen Wang, Kehe Chen, Ximing Xu, Cuiping Zheng, Yanzhi Bi, Sijuan Ding, Jingdong Zhang, Wei Li, Hailong Liu, Jun Wang, Xianling Liu, Yangfeng Du, Lianming Cai, Jingran Wang, Zhanxiong Luo, Baocai Xing, Jie Shen, Lin Yang, Jianbing Wu, Ou Jiang, Zhigang Peng, Xiuli Liu, Bangwei Cao, Liangfang Shen, Aibing Xu, Aimin Li, Shaojun Chen, Ting Fu, Jian Chen, Chuan Jin, Lei Zhang, Jun Lv, Chengwu Zhang, Xiaoman Zhang, Yu Wang, Huo Su, Qiang Zhou, Wenlin Gai, Liangzhi Xie, Jianming Xu
Published 2025-08-01Get full text
Article